1. Home
  2. GKOS vs TXT Comparison

GKOS vs TXT Comparison

Compare GKOS & TXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • TXT
  • Stock Information
  • Founded
  • GKOS 1998
  • TXT 1923
  • Country
  • GKOS United States
  • TXT United States
  • Employees
  • GKOS N/A
  • TXT N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • TXT Aerospace
  • Sector
  • GKOS Health Care
  • TXT Industrials
  • Exchange
  • GKOS Nasdaq
  • TXT Nasdaq
  • Market Cap
  • GKOS 5.8B
  • TXT 13.9B
  • IPO Year
  • GKOS 2015
  • TXT N/A
  • Fundamental
  • Price
  • GKOS $103.50
  • TXT $82.23
  • Analyst Decision
  • GKOS Strong Buy
  • TXT Buy
  • Analyst Count
  • GKOS 13
  • TXT 11
  • Target Price
  • GKOS $135.15
  • TXT $87.82
  • AVG Volume (30 Days)
  • GKOS 903.0K
  • TXT 1.5M
  • Earning Date
  • GKOS 07-30-2025
  • TXT 07-24-2025
  • Dividend Yield
  • GKOS N/A
  • TXT 0.10%
  • EPS Growth
  • GKOS N/A
  • TXT N/A
  • EPS
  • GKOS N/A
  • TXT 4.44
  • Revenue
  • GKOS $404,523,000.00
  • TXT $13,873,000,000.00
  • Revenue This Year
  • GKOS $27.88
  • TXT $8.12
  • Revenue Next Year
  • GKOS $27.60
  • TXT $4.69
  • P/E Ratio
  • GKOS N/A
  • TXT $18.52
  • Revenue Growth
  • GKOS 23.92
  • TXT 0.57
  • 52 Week Low
  • GKOS $77.10
  • TXT $57.70
  • 52 Week High
  • GKOS $163.71
  • TXT $94.57
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 61.38
  • TXT 77.16
  • Support Level
  • GKOS $100.92
  • TXT $78.37
  • Resistance Level
  • GKOS $106.52
  • TXT $81.16
  • Average True Range (ATR)
  • GKOS 3.30
  • TXT 1.52
  • MACD
  • GKOS 0.37
  • TXT 0.30
  • Stochastic Oscillator
  • GKOS 71.27
  • TXT 97.71

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About TXT Textron Inc.

Textron is a conglomerate that designs, manufactures, and services a range of specialty aircraft including small jets, propeller-driven airplanes, helicopters, and tilt-rotor aircraft. Textron Aviation manufactures and services Cessna and Beechcraft planes. Bell is a helicopter and tilt-rotor manufacturer and servicer for both commercial and military customers. Textron Systems produces uncrewed aircraft and armored vehicles for the military market as well as aircraft simulators and training for the commercial and military markets. Textron Industrial contains the Kautex business, which manufactures plastic fuel tanks for conventional and hybrid motor vehicles, and other subsidiaries that produce specialized vehicles such as golf carts and all-terrain vehicles.

Share on Social Networks: